Outcome	Type	SUPPRESSION BY CD14+	SUPPRESSION BY SN CD14+	SUPPRESSION BY SN CD66b+ LDN	SUPPRESSION BY SN CD66b+ NDN
alive	Severe	78,5	52,11	96,4	41,6
alive	Severe	42,6	35,2	96,3	18,9
dead	Severe	10,2	25,63	52,33	18,6
alive	Severe	67,4	56,8	94,7	34,56
alive	Severe	10,59	4,89	31,55	1,85
alive	Severe	35,3	67,4	95,6	21,3
dead	Severe	25,6	31,25	84,59	24,78
alive	Severe				
alive	Severe				
dead	Severe				
alive	Severe	62,3	87,66	69,88	12,52
dead	Severe	18,56	1,52	19,63	11,89
alive	Severe	39,6	54,78	84,23	34,7
alive	Severe	24,6	35,6	49,89	35,6
alive	Severe	62,74	45,88	68,54	12,58
dead	Severe	20,33	2,53	24,3	10,56
dead	Severe				
alive	Severe	74,55	52,63	52,7	47,89
dead	Severe	15,66	56,87	74,85	18,99
dead	Severe	14,78	0,87	25,12	4,89
alive	Severe	52,36	51,29	42,66	23,44
dead	Severe	12,3	15,6	21,5	18,9
dead	Severe				
	mild				
	mild	65,3	78,69	76,3	5,23
	mild	69,14	35,96	74,09	15,08
	mild	54,87	41,78	57,88	14,89
	mild				
	mild				
	mild	45,99	74,56	87,85	21,45
	mild	74,52	58,96	95,23	41,26
	mild	85,12	63,22	91,02	38,78
	mild	58,7	78,99	96,33	45,12
	healthy donor	4,45	1,58		24,66
	healthy donor				
	healthy donor	24,33	4,89		12,78
	healthy donor	10,47	5,54		11,48
	healthy donor	10,89	15,48		11,55